Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neurosurg Rev ; 46(1): 308, 2023 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-37985473

RESUMEN

The incidence of pneumonia in ICU patients with TBI is very high, seriously affecting the prognosis. This study aims to construct a predictive model for pneumonia in ICU patients with TBI and provide help for the prevention of TBI-related pneumonia.Clinical data of ICU patients with TBI were collected from the Medical Information Mart for Intensive Care (MIMIC)-IV database and hospital data. Variables were screened by lasso and multivariate logistic regression to construct a predictive nomogram model, verified in internal validation cohort and external validation cohort by receiver operator characteristic (ROC) curve, calibration curve and decision curve analysis (DCA).A total of 1850 ICU patients with TBI were enrolled in the study from the MIMIC-IV database, including 1298 in the training cohort and 552 in internal validation cohort. The external validation cohort included 240 ICU patients with TBI from hospital data. Nine variables were selected from the training cohort by lasso regression and multivariate logistic regression, and a pneumonia prediction nomogram was constructed. This nomogram has a high discrimination in training, internal validation and external validation cohorts (AUC = 0.857, 0.877, 0.836). The calibration curve and DCA showed that this nomogram had a high calibration and better clinical decision-making efficiency.The nomogram showed excellent discrimination and clinical utility to predict pneumonia, and could identify pneumonia high-risk patients early, thus providing personalised treatment strategies for ICU patients with TBI.


Asunto(s)
Lesiones Traumáticas del Encéfalo , Neumonía , Humanos , Nomogramas , Lesiones Traumáticas del Encéfalo/complicaciones , Toma de Decisiones Clínicas , Unidades de Cuidados Intensivos
2.
Chem Commun (Camb) ; 59(83): 12479-12482, 2023 Oct 17.
Artículo en Inglés | MEDLINE | ID: mdl-37782535

RESUMEN

Layer-by-layer assembly of strong polyelectrolytes was successfully implemented on hydrophobic particles in degassed saline water thanks to de-gassing-reduced hydrophobic interactions and salinity-reduced hydration. The resulting polyelectrolyte multilayer coated particles were readily converted to hydrophobic yolk/hydrophilic shell particles for the removal of organic dyes from water via both electrostatic and hydrophobic interactions.

3.
Curr Oncol ; 29(11): 8374-8389, 2022 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-36354720

RESUMEN

BACKGROUND: Large epidemiological studies describing the trends in incidence rates and mortality of synchronous brain metastases (SBMs) are lacking. The study aimed to provide a comprehensive understanding of the changes in the incidence and mortality of SBMs over the previous ten years. METHODS: Trends in the incidence of solid malignancies outside of the CNS in patients with SBMs and incidence-based mortality rates were assessed using data from the Surveillance, Epidemiology, and End Results database. Joinpoint analyses were used to calculate annual percent changes (APCs) and 95% CIs. RESULTS: Between 2010 and 2019, 66,655 patients, including 34,821 (52.24%) men and 31,834 (47.76%) women, were found to have SBMs, and 57,692 deaths occurred over this period. Lung cancer SBMs, melanoma SBMs, and breast cancer SBMs were ranked in the top three, having the highest age-standardized incidence rates. The incidence of SBMs decreased significantly with an APC of -0.6% from 2010 to 2019, while the APC was 1.2% for lung cancer SBMs, 2.5% for melanoma SBMs, and 0.6% for breast cancer SBMs. The SBM mortality first experienced a rapid increase (APC = 28.6%) from 2010 to 2012 and then showed a significant decline at an APC of -1.8% from 2012 to 2019. Lung cancer SBMs showed similar trends, while melanoma SBM and breast cancer SBM mortality increased continuously. CONCLUSIONS: SBMs incidence (2010-2019) and incidence-based mortality (2012-2019) declined significantly. These findings can advance our understanding of the prevalence of SBMs.


Asunto(s)
Neoplasias Encefálicas , Neoplasias de la Mama , Neoplasias Pulmonares , Melanoma , Masculino , Estados Unidos/epidemiología , Humanos , Femenino , Incidencia , Neoplasias Encefálicas/epidemiología , Neoplasias Pulmonares/epidemiología , Melanoma/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...